4d Molecular Therapeutics In shares owned by Woodline Partners
Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Woodline Partners
from 13F filings
Historical chart of Woodline Partners investment in 4d Molecular Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including 4d Molecular Therapeutics In held by Woodline Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in 4d Molecular Therapeutics In by Woodline Partners
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $1.5M | 200k | 7.50 |
| 2021-12-31 | $2.9M | 132k | 21.94 |
| 2021-09-30 | $2.3M | 86k | 26.97 |
| 2021-06-30 | $932k | 39k | 24.08 |
| 2021-03-31 | $3.7M | 86k | 43.38 |
| 2020-12-31 | $4.3M | 104k | 41.45 |